Sfoglia per Autore
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias
2019 Pillozzi S.; Bernini A.; Spiga O.; Lelli B.; Petroni G.; Bracci L.; Niccolai N.; Arcangeli A.
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin
2019 Damiano Cirri, Maria Giulia Fabbrini, Lara Massai, Serena Pillozzi, Annalisa Guerri, Alessio Menconi, Luigi Messori, Tiziano Marzo, Alessandro Pratesi
hERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma
2019 Lastraioli E.; Pillozzi S.; Mari A.; Tellini R.; Duranti C.; Baldazzi V.; Venturini S.; Minervini A.; Lapini A.; Nesi G.; Carini M.; Arcangeli A.
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer
2019 Tiziano Marzo, Lara Massai, Alessandro Pratesi, Matteo Stefanini, Damiano Cirri, Francesca Magherini, Matteo Becatti, Ida Landini, Stefania Nobili, Enrico Mini, Olivia Crociani, Annarosa Arcangeli, Serena Pillozzi, Tania Gamberi, Luigi Messori
Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer
2019 Petroni G.; Stefanini M.; Pillozzi S.; Crociani O.; Becchetti A.; Arcangeli A.
The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma
2019 Magi A.; Masselli M.; Sala C.; Guerriero A.; Laise P.; Puccini B.; Rigacci L.; Breschi C.; Crociani O.; Pillozzi S.; Arcangeli A.; Serena Pillozzi
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?
2020 Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Vergoni F, Amunni G, Fambrini M, Petraglia F, Noci I, Pillozzi S
Immune checkpoint inhibitors in the treatment of renal cancer: Current state and future perspective
2020 Lavacchi D.; Pellegrini E.; Palmieri V.E.; Doni L.; Mela M.M.; Di Maida F.; Amedei A.; Pillozzi S.; Carini M.; Antonuzzo L.
Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma
2020 Fantappie G.; Malentacchi F.; Turrini I.; Sorbi F.; Castiglione F.; Vergoni F.; Ammatuna C.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S.
ROS1 rearrangements are uncommon in biliary tract cancers
2020 Mazzoni, Francesca; Petreni, Paolo; Vasile, Enrico; Panebianco, Michele; Casadei-Gardini, Andrea; Negri, Francesca; Lunghi, Alice; Pillozzi, Serena; Vivaldi, Caterina; Gervasi, Erika; Frassineti, Giovanni Luca; Messerini, Luca; Jocollé, Genny; Bisagni, Alessandra; Antonuzzo, Lorenzo; Rossi, Giulio
Mutational profile in circulating tumor DNA in a patient affected by low-risk endometrial cancer: Predictable tool of relapse?
2020 Malentacchia F.; Turrini I.; Zepponi F.; Fantappie G.; Sorbi F.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S.
Somatostatin analogs in pregnant patients with neuroendocrine tumor
2020 Meoni, Giulia; Giommoni, Elisa; Petreni, Paolo; Pillozzi, Serena; Mazzoni, Francesca; Pellegrini, Elisa; Brugia, Marco; Lunghi, Alice; Muto, Andrea; Antonuzzo, Lorenzo
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
2021 Vultaggio, Alessandra; Petrella, Maria Cristina; Tomao, Federica; Nencini, Francesca; Mecheri, Valentina; Marini, Andrea; Perlato, Margherita; Vivarelli, Emanuele; De Angelis, Claudia; Ferrarini, Ilaria; Pillozzi, Serena; Matucci, Andrea; Antonuzzo, Lorenzo
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives
2021 Fancelli S.; Caliman E.; Mazzoni F.; Brugia M.; Castiglione F.; Voltolini L.; Pillozzi S.; Antonuzzo L.
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis
2021 Paderi A.; Gambale E.; Botteri C.; Giorgione R.; Lavacchi D.; Brugia M.; Mazzoni F.; Giommoni E.; Bormioli S.; Amedei A.; Pillozzi S.; Cerinic M.M.; Antonuzzo L.
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience
2021 Lavacchi D.; Roviello G.; Giommoni E.; Dreoni L.; Derio S.; Brugia M.; Amedei A.; Pillozzi S.; Antonuzzo L.
Results of the observational prospective RealFLOT study
2021 Giommoni, Elisa; Lavacchi, Daniele; Tirino, Giuseppe; Fornaro, Lorenzo; Iachetta, Francesco; Pozzo, Carmelo; Satolli, Maria Antonietta; Spallanzani, Andrea; Puzzoni, Marco; Stragliotto, Silvia; Sisani, Michele; Formica, Vincenzo; Giovanardi, Filippo; Strippoli, Antonia; Prisciandaro, Michele; Di Donato, Samantha; Pompella, Luca; Pecora, Irene; Romagnani, Alessandra; Fancelli, Sara; Brugia, Marco; Pillozzi, Serena; De Vita, Ferdinando; Antonuzzo, Lorenzo
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study
2021 Paderi, Agnese; Fancelli, Sara; Caliman, Enrico; Pillozzi, Serena; Gambale, Elisabetta; Mela, Marinella Micol; Doni, Laura; Mazzoni, Francesca; Antonuzzo, Lorenzo
Circulating miRNome profiling data in Behçet's syndrome
2021 Bagni, Giacomo; Emmi, Giacomo; Lastraioli, Elena; Patti, Francesca Di; Silvestri, Elena; Guerriero, Angela; Pillozzi, Serena; Niccolai, Elena; Amedei, Amedeo; Emmi, Lorenzo; Prisco, Domenico; Arcangeli, Annarosa
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
2021 Paderi, Agnese; Giorgione, Roberta; Giommoni, Elisa; Mela, Marinella Micol; Rossi, Virginia; Doni, Laura; Minervini, Andrea; Carini, Marco; Pillozzi, Serena; Antonuzzo, Lorenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias | 2019 | Pillozzi S.; Bernini A.; Spiga O.; Lelli B.; Petroni G.; Bracci L.; Niccolai N.; Arcangeli A. | |
| Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin | 2019 | Damiano Cirri, Maria Giulia Fabbrini, Lara Massai, Serena Pillozzi, Annalisa Guerri, Alessio Menconi, Luigi Messori, Tiziano Marzo, Alessandro Pratesi | |
| hERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma | 2019 | Lastraioli E.; Pillozzi S.; Mari A.; Tellini R.; Duranti C.; Baldazzi V.; Venturini S.; Minervini A.; Lapini A.; Nesi G.; Carini M.; Arcangeli A. | |
| Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer | 2019 | Tiziano Marzo, Lara Massai, Alessandro Pratesi, Matteo Stefanini, Damiano Cirri, Francesca Magherini, Matteo Becatti, Ida Landini, Stefania Nobili, Enrico Mini, Olivia Crociani, Annarosa Arcangeli, Serena Pillozzi, Tania Gamberi, Luigi Messori | |
| Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer | 2019 | Petroni G.; Stefanini M.; Pillozzi S.; Crociani O.; Becchetti A.; Arcangeli A. | |
| The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma | 2019 | Magi A.; Masselli M.; Sala C.; Guerriero A.; Laise P.; Puccini B.; Rigacci L.; Breschi C.; Crociani O.; Pillozzi S.; Arcangeli A.; Serena Pillozzi | |
| Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value? | 2020 | Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Vergoni F, Amunni G, Fambrini M, Petraglia F, Noci I, Pillozzi S | |
| Immune checkpoint inhibitors in the treatment of renal cancer: Current state and future perspective | 2020 | Lavacchi D.; Pellegrini E.; Palmieri V.E.; Doni L.; Mela M.M.; Di Maida F.; Amedei A.; Pillozzi S.; Carini M.; Antonuzzo L. | |
| Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma | 2020 | Fantappie G.; Malentacchi F.; Turrini I.; Sorbi F.; Castiglione F.; Vergoni F.; Ammatuna C.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S. | |
| ROS1 rearrangements are uncommon in biliary tract cancers | 2020 | Mazzoni, Francesca; Petreni, Paolo; Vasile, Enrico; Panebianco, Michele; Casadei-Gardini, Andrea; Negri, Francesca; Lunghi, Alice; Pillozzi, Serena; Vivaldi, Caterina; Gervasi, Erika; Frassineti, Giovanni Luca; Messerini, Luca; Jocollé, Genny; Bisagni, Alessandra; Antonuzzo, Lorenzo; Rossi, Giulio | |
| Mutational profile in circulating tumor DNA in a patient affected by low-risk endometrial cancer: Predictable tool of relapse? | 2020 | Malentacchia F.; Turrini I.; Zepponi F.; Fantappie G.; Sorbi F.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S. | |
| Somatostatin analogs in pregnant patients with neuroendocrine tumor | 2020 | Meoni, Giulia; Giommoni, Elisa; Petreni, Paolo; Pillozzi, Serena; Mazzoni, Francesca; Pellegrini, Elisa; Brugia, Marco; Lunghi, Alice; Muto, Andrea; Antonuzzo, Lorenzo | |
| The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer | 2021 | Vultaggio, Alessandra; Petrella, Maria Cristina; Tomao, Federica; Nencini, Francesca; Mecheri, Valentina; Marini, Andrea; Perlato, Margherita; Vivarelli, Emanuele; De Angelis, Claudia; Ferrarini, Ilaria; Pillozzi, Serena; Matucci, Andrea; Antonuzzo, Lorenzo | |
| Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives | 2021 | Fancelli S.; Caliman E.; Mazzoni F.; Brugia M.; Castiglione F.; Voltolini L.; Pillozzi S.; Antonuzzo L. | |
| Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis | 2021 | Paderi A.; Gambale E.; Botteri C.; Giorgione R.; Lavacchi D.; Brugia M.; Mazzoni F.; Giommoni E.; Bormioli S.; Amedei A.; Pillozzi S.; Cerinic M.M.; Antonuzzo L. | |
| Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience | 2021 | Lavacchi D.; Roviello G.; Giommoni E.; Dreoni L.; Derio S.; Brugia M.; Amedei A.; Pillozzi S.; Antonuzzo L. | |
| Results of the observational prospective RealFLOT study | 2021 | Giommoni, Elisa; Lavacchi, Daniele; Tirino, Giuseppe; Fornaro, Lorenzo; Iachetta, Francesco; Pozzo, Carmelo; Satolli, Maria Antonietta; Spallanzani, Andrea; Puzzoni, Marco; Stragliotto, Silvia; Sisani, Michele; Formica, Vincenzo; Giovanardi, Filippo; Strippoli, Antonia; Prisciandaro, Michele; Di Donato, Samantha; Pompella, Luca; Pecora, Irene; Romagnani, Alessandra; Fancelli, Sara; Brugia, Marco; Pillozzi, Serena; De Vita, Ferdinando; Antonuzzo, Lorenzo | |
| Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study | 2021 | Paderi, Agnese; Fancelli, Sara; Caliman, Enrico; Pillozzi, Serena; Gambale, Elisabetta; Mela, Marinella Micol; Doni, Laura; Mazzoni, Francesca; Antonuzzo, Lorenzo | |
| Circulating miRNome profiling data in Behçet's syndrome | 2021 | Bagni, Giacomo; Emmi, Giacomo; Lastraioli, Elena; Patti, Francesca Di; Silvestri, Elena; Guerriero, Angela; Pillozzi, Serena; Niccolai, Elena; Amedei, Amedeo; Emmi, Lorenzo; Prisco, Domenico; Arcangeli, Annarosa | |
| Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors | 2021 | Paderi, Agnese; Giorgione, Roberta; Giommoni, Elisa; Mela, Marinella Micol; Rossi, Virginia; Doni, Laura; Minervini, Andrea; Carini, Marco; Pillozzi, Serena; Antonuzzo, Lorenzo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile